- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02901821
Predicting Concussion Outcomes With Salivary miRNA
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to characterize longitudinal salivary RNA expression in 600 children with mTBI and identify RNA patterns that predict length and characterof concussive symptoms, as well as the response to therapy.
Hypothesis: Specific RNAs will be differentially regulated in children with prolonged mTBI symptoms across the acute and sub-acute time periods. The investigators predict that a set of RNAs with differential expression in children with mTBI will be statistically associated with functional measures of mTBI symptoms as well as the duration of concussive symptoms.
Rationale: Preliminary studies show that miRNA is altered in adults with varying degrees of TBI and that salivary RNA is altered by disorders of the CNS. These studies indicate that serum-based miRNA may be used as an accurate biomarker for differentiating adults with and without TBI. Whether similar patterns can seen in the saliva of children following mTBI remains to be seen. Furthermore, the influence of confounding variables such as gender, mechanism of injury, and previous mTBIs on RNA profiles has not been explored. The investigators propose to investigate these questions by examining salivary RNA from 600 children (ages five to twenty-one years) with a clinical diagnosis of mTBI (as well as 100 age-and gender-matched controls, recruited from the Penn State Pediatric Concussion Clinic, Emergency Department, and the affiliated primary care clinics). The investigators plan to prospectively follow 600 children with mTBI for 1-month post-concussion, tracking subjective symptoms with the Child Sports Concussion Assessment Tool (SCAT-5), and objective symptoms of balance and cognition. Saliva will be collected via swab at three time-points (at initial clinical presentation, 1-2 weeks, and 4-weeks after the date of initial mTBI). Expression of salivary RNA taken at initial presentation will be compared against symptom duration (where prolonged post-concussive symptoms are defined as those lasting >4 weeks) and character (as measured numerically by Post-concussion symptom inventory self-report and ClearEdge scoring). The investigators plan to identify a set of salivary RNAs that can easily be used to predict clinical course for pediatric patients following a diagnosis of mTBI.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Steven Hicks, MD, PhD
- Phone Number: 7175318006
- Email: shicks1@hmc.psu.edu
Study Locations
-
-
Pennsylvania
-
Hershey, Pennsylvania, United States, 17033
- Recruiting
- Penn State Milton S. Hershey Medical Center
-
Contact:
- Steven Hicks, MD, PhD
- Phone Number: 717-531-8006
- Email: shicks1@hmc.psu.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- 5-21 years with mild traumatic brain injury that occurred within 7 days of enrollment
Exclusion Criteria:
- Sever traumatic brain injury
- Skull fracture
- Concurrent upper respiratory infection
- Patients whose primary language is not English
- Periodontal infection
- Wards of the state
- Ongoing seizure disorder,
- Drug or alcohol dependency
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Control
No intervention.
Collection of medical/demographic info and salivary RNA in children 5-21 years without history of mild traumatic brain injury (mTBI).
|
collection of saliva for microRNA (small noncoding RNA) processing
|
Concussion
Collection of medical/demographic info and salivary RNA in children 5-21 years with history of mild traumatic brain injury (mTBI).
Collection of PCSI concussion assessment interview tool and balance/cognition testing at time of injury, 1-2wks post injury, and 4wks post injury.
|
collection of saliva for microRNA (small noncoding RNA) processing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence or absence of concussion symptoms
Time Frame: 4-weeks post injury
|
subjective (score >7 on PCSI) or objective (score outside 85 percentile on accelerometer balance testing or cognitive testing)
|
4-weeks post injury
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Salivary RNA profile
Time Frame: Within 7d of initial injury, 1-2 weeks post-injury, and 4-weeks post-injury
|
measured with RNAseq
|
Within 7d of initial injury, 1-2 weeks post-injury, and 4-weeks post-injury
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Steven Hicks, MD, PhD, Milton S. Hershey Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00003729
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Concussion, Mild
-
Children's Hospital of PhiladelphiaNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingMild Traumatic Brain Injury | Concussion, Mild | Concussion, Severe | Concussion, IntermediateUnited States
-
Sync-Think, Inc.CompletedBrain Injuries | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion; Eye | Concussion, CerebralUnited States
-
BrainScope Company, Inc.CompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.CompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.United States Department of DefenseCompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.CompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.United States Department of DefenseCompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
Medstar Health Research InstituteNot yet recruitingConcussion, Mild | Concussion, Severe | Concussion, Intermediate
-
University of British ColumbiaUnknownConcussion | Sport-related Concussion | Mild Traumatic Brain Injury (MTBI)Canada
-
Sports Surgery Clinic, Santry, DublinCompletedConcussion, Mild | Concussion, Severe | Concussion, IntermediateIreland
Clinical Trials on salivary RNA collection
-
University Hospital, Basel, SwitzerlandSchulzahnklinik Basel; Volkszahnklinik BaselCompleted
-
Institut National de la Santé Et de la Recherche...Commissariat A L'energie AtomiqueActive, not recruiting
-
Hospices Civils de LyonCompleted
-
IRCCS Centro Neurolesi "Bonino-Pulejo"Regione SiciliaRecruitingAutism Spectrum DisorderItaly
-
University of Wisconsin, MadisonCompletedHead and Neck Cancer | XerostomiaUnited States
-
Istanbul Medipol University HospitalCompletedPeriodontitis | Diagnoses DiseaseTurkey
-
University Hospital, Strasbourg, FranceTerminated
-
Medical Centre LeeuwardenUniversity Medical Center GroningenCompletedHypernatremiaNetherlands
-
Hadassah Medical OrganizationUnknown
-
Hadassah Medical OrganizationUnknownGastric Cancer | Pancreatic Cancer | Colorectal Cancer and Pre-cancer PolypsIsrael